Results 151 to 160 of about 18,546 (173)

Anakinra

Reactions Weekly, 2014
openaire   +2 more sources

Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy

International Journal of Molecular Sciences, 2021
Gaku Yamanaka, Shinji Suzuki, Tomoko Takamatsu   +2 more
exaly  

Off-Label studies on anakinra in dermatology: a review

Journal of Dermatological Treatment, 2022
Kyle Tegtmeyer, Giancarlo Atassi, Jeffrey Zhao   +2 more
exaly  

Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study

European Journal of Preventive Cardiology, 2020
Massimo Imazio, Alessandro Andreis, Gaetano Maria De Ferrari   +2 more
exaly  

The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis

Journal of Clinical Medicine, 2021
Konstantinos G Kyriakoulis, Anastasios Kollias, Garyphallia Poulakou   +2 more
exaly  

Effects of anakinra on the small intestine mucositis induced by methotrexate in rats

Experimental Animals, 2020
Ali Veysel Kara, Emin Murat AkbaŞ, Nezahat Kurt   +2 more
exaly  

A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID‐19

Immunity, Inflammation and Disease, 2022
Amir Behnam Kharazmi, Omid Moradi, Mehrdad Haghighi   +2 more
exaly  

The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series

Autoimmunity Reviews, 2018
Isabelle Koné-Paut, Rolando Cimaz, Jethro Herberg   +2 more
exaly  

Anakinra

Reactions Weekly, 2015
  +4 more sources

Anakinra's Efficacy is Variable in Refractory Gout: Report of Ten Cases

Seminars in Arthritis and Rheumatism, 2010
Theodore Fields, Anne R Bass
exaly